--- title: "Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025" description: "Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September ..." type: "news" locale: "en" url: "https://longbridge.com/en/news/252341109.md" published_at: "2025-08-09T16:09:46.000Z" --- # Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 > Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September ... Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September ... ### Related Stocks - [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | [Link](https://longbridge.com/en/news/270794581.md) | | Novo Nordisk to sell Wegovy pill to US self-pay patients starting at $149 per month | COPENHAGEN, Jan 5 (Reuters) - Denmark’s Novo Nordisk (NOVOb.CO) will offer its 1.5 and 4 milligram Wegovy weightloss pil | [Link](https://longbridge.com/en/news/271483295.md) | | Uber Enters 7 New European Markets In Food Delivery Push- FT | UBER ENTERS 7 NEW EUROPEAN MARKETS IN FOOD DELIVERY PUSH- FT | [Link](https://longbridge.com/en/news/275995937.md) | | Codeifai Enters AI-Backed Quantum Security Market | Codeifai Ltd :CODEIFAI ENTERS AI-BACKED QUANTUM SECURITY MARKETCOMPLETION OF ACQUISITION OF ANTENNATRANSFER.IOTOTAL CONS | [Link](https://longbridge.com/en/news/276015719.md) | | Huatai Securities Reaffirms Their Buy Rating on Hong Kong Exchanges & Clearing (HKXCF) | In a report released yesterday, from Huatai Securities maintained a Buy rating on Hong Kong Exchanges & Clearing, with a | [Link](https://longbridge.com/en/news/275995421.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.